Drug Shortage Report for VIOKACE
Report ID | 73800 |
Drug Identification Number | 02241933 |
Brand name | VIOKACE |
Common or Proper name | VIOKACE 20880 |
Company Name | NESTLE ENTERPRISES S.A. |
Market Status | MARKETED |
Active Ingredient(s) | AMYLASE PROTEASE LIPASE |
Strength(s) | 113400UNIT 112500UNIT 20880UNIT |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100's count bottle |
ATC code | A09AA |
ATC description | DIGESTIVES, INCL ENZYMES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-03-08 |
Actual start date | 2019-03-05 |
Estimated end date | 2019-06-21 |
Actual end date | 2019-05-31 |
Shortage status | Resolved |
Updated date | 2019-06-01 |
Company comments | Delay with Viokase 20880 (SKU 20494) product release and raw material replenishment. Viokace 10440 (SKU 20495) remains available to alleviate impact. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 12, RUE ENTRE-DEUX-VILLES VEVEY, -- SWITZERLAND 1800 |
Company contact information | kfeltmate@apcipharma.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2019-06-01 | English | Compare |
v15 | 2019-05-31 | French | Compare |
v14 | 2019-05-31 | English | Compare |
v13 | 2019-05-22 | French | Compare |
v12 | 2019-05-22 | English | Compare |
v11 | 2019-04-25 | French | Compare |
v10 | 2019-04-25 | English | Compare |
v9 | 2019-03-06 | English | Compare |
v8 | 2019-03-05 | French | Compare |
v7 | 2019-03-05 | English | Compare |
v6 | 2019-02-08 | French | Compare |
v5 | 2019-02-08 | English | Compare |
v4 | 2019-02-07 | French | Compare |
v3 | 2019-02-07 | English | Compare |
v2 | 2019-01-29 | French | Compare |
v1 | 2019-01-29 | English | Compare |
Showing 1 to 16 of 16